ArticleLife (Basel, Switzerland)2023

A New Anticancer Semisynthetic Theobromine Derivative Targeting EGFR Protein: CADDD Study.

Ibrahim H Eissa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.